Stay updated on Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.

Latest updates to the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page
- Check5 days agoChange DetectedThe revision label updated from v3.6.5 to v3.6.6, signaling a small site update without changes to the study information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page shows a revision bump from v3.6.4 to v3.6.5, indicating a small update to the page’s version. This change mostly reflects backend or template updates rather than alterations to study content or visible information.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's revision tag changed from v3.6.3 to v3.6.4, signaling a new software revision of the page. This update appears to affect the UI/backend version rather than the study data.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.2 on the page, indicating a new version of the ClinicalTrials.gov study record.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision has been updated to v3.6.2, replacing the previous v3.6.0. This appears to be a minor internal release update without changes to study content or user-facing features.SummaryDifference0.1%

- Check83 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and an Intervention/Treatment header; the old Intervention / Treatment header and a prior revision note were removed.SummaryDifference0.5%

Stay in the know with updates to Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.